Behavioral Health Drug Trends: 2025 Mid-Year Check In is starting in

Opioid Use Disorder: Treatment With Injectable & Implantable Buprenorphine

In August 2020, the U.S. Government Accountability Office (ACO) published a report focused on injectable and implantable controlled substances that can be used to treat opioid use disorder (OUD), and specifically, describes the process for treating OUD with injectable and implantable buprenorphine and what is known about their use . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.